CA Stock MarketDetailed Quotes

NurExone Biologic Inc (NRX)

Watchlist
  • 0.590
  • -0.040-6.35%
15min DelayMarket Closed Apr 24 16:00 ET
54.31MMarket Cap-5.36P/E (TTM)

NurExone Biologic Inc (NRX) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
205.43%2.14M
205.43%2.14M
-61.04%983K
-48.51%1.23M
-81.94%588K
29.39%700K
29.39%700K
120.73%2.52M
171.02%2.39M
104.97%3.26M
-Cash and cash equivalents
205.43%2.14M
205.43%2.14M
-61.04%983K
-48.51%1.23M
-81.94%588K
29.39%700K
29.39%700K
120.73%2.52M
171.02%2.39M
104.97%3.26M
Receivables
-29.92%89K
-29.92%89K
-52.90%122K
-76.54%84K
-65.38%135K
29.59%127K
29.59%127K
215.85%259K
165.19%358K
50.58%390K
-Taxes receivable
-37.10%78K
-37.10%78K
----
----
----
39.33%124K
39.33%124K
----
----
----
-Other receivables
266.67%11K
266.67%11K
-52.90%122K
-76.54%84K
-65.38%135K
-66.67%3K
-66.67%3K
215.85%259K
165.19%358K
50.58%390K
Prepaid assets
-87.60%95K
-87.60%95K
--0
--600K
--600K
571.93%766K
571.93%766K
----
----
----
Restricted cash
580.49%279K
580.49%279K
0.00%41K
0.00%41K
28.13%41K
-96.66%41K
-96.66%41K
-24.07%41K
-24.07%41K
-40.74%32K
Total current assets
59.18%2.6M
59.18%2.6M
-59.40%1.15M
-29.85%1.95M
-62.90%1.36M
-17.56%1.63M
-17.56%1.63M
120.72%2.82M
160.43%2.78M
93.42%3.68M
Non current assets
Net PPE
7.06%864K
7.06%864K
11.50%882K
79.33%911K
66.88%776K
329.26%807K
329.26%807K
499.24%791K
257.75%508K
225.17%465K
-Gross PPE
26.88%1.11M
26.88%1.11M
11.50%882K
79.33%911K
66.88%776K
336.82%878K
336.82%878K
499.24%791K
257.75%508K
225.17%465K
-Accumulated depreciation
-252.11%-250K
-252.11%-250K
----
----
----
-446.15%-71K
-446.15%-71K
----
----
----
Other non current assets
--618K
--618K
--618K
----
----
----
----
----
----
----
Total non current assets
83.64%1.48M
83.64%1.48M
89.63%1.5M
79.33%911K
66.88%776K
329.26%807K
329.26%807K
499.24%791K
257.75%508K
225.17%465K
Total assets
67.27%4.08M
67.27%4.08M
-26.78%2.65M
-13.00%2.86M
-48.33%2.14M
12.49%2.44M
12.49%2.44M
156.13%3.61M
171.84%3.29M
102.64%4.14M
Liabilities
Current liabilities
Current debt and capital lease obligation
1,800.00%38K
1,800.00%38K
----
----
----
-88.89%2K
-88.89%2K
----
----
----
-Current capital lease obligation
1,800.00%38K
1,800.00%38K
----
----
----
-88.89%2K
-88.89%2K
----
----
----
Payables
-54.39%26K
-54.39%26K
88.59%496K
82.75%678K
258.82%366K
14.00%57K
14.00%57K
-25.71%263K
142.48%371K
-61.94%102K
-Other payable
-54.39%26K
-54.39%26K
88.59%496K
82.75%678K
258.82%366K
14.00%57K
14.00%57K
447.92%263K
142.48%371K
-61.94%102K
Current accrued expenses
103.54%690K
103.54%690K
112.79%366K
90.17%329K
-19.05%187K
-38.14%339K
-38.14%339K
-36.06%172K
-39.08%173K
-23.26%231K
Current deferred liabilities
----
----
----
----
----
--0
--0
--0
--2K
--29K
Other current liabilities
--235K
--235K
----
----
----
----
----
----
----
----
Current liabilities
148.49%989K
148.49%989K
98.16%862K
84.43%1.01M
52.76%553K
-79.14%398K
-79.14%398K
-30.18%435K
24.94%546K
-36.38%362K
Non current liabilities
Long term debt and capital lease obligation
125.81%70K
125.81%70K
154.84%79K
264.00%91K
29.17%31K
1,450.00%31K
1,450.00%31K
933.33%31K
177.78%25K
84.62%24K
-Long term capital lease obligation
125.81%70K
125.81%70K
154.84%79K
264.00%91K
29.17%31K
1,450.00%31K
1,450.00%31K
933.33%31K
177.78%25K
84.62%24K
Long term accounts payable and other payables
-29.49%55K
-29.49%55K
-39.44%43K
-43.75%36K
-28.21%56K
9.86%78K
9.86%78K
10.94%71K
-14.67%64K
14.71%78K
Non current deferred liabilities
21.97%211K
21.97%211K
37.58%205K
141.46%198K
291.49%184K
--173K
--173K
--149K
--82K
--47K
Total non current liabilities
19.15%336K
19.15%336K
30.28%327K
90.06%325K
81.88%271K
286.30%282K
286.30%282K
274.63%251K
103.57%171K
83.95%149K
Total liabilities
94.85%1.33M
94.85%1.33M
73.32%1.19M
85.77%1.33M
61.25%824K
-65.67%680K
-65.67%680K
-0.58%686K
37.62%717K
-21.38%511K
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Additional paid-in capital
34.04%26.09M
34.04%26.09M
33.97%23.82M
35.21%22.75M
23.74%20.41M
46.37%19.47M
46.37%19.47M
46.29%17.78M
49.21%16.83M
46.38%16.5M
Retained earnings
-33.42%-25.48M
-33.42%-25.48M
-37.23%-24.09M
-38.76%-22.62M
-38.71%-20.78M
-35.88%-19.1M
-35.88%-19.1M
-31.79%-17.55M
-34.05%-16.3M
-34.67%-14.98M
Gains losses not affecting retained earnings
116.34%33K
116.34%33K
58.72%-45K
67.38%-46K
-142.22%-218K
-348.89%-202K
-348.89%-202K
-81.67%-109K
-67.86%-141K
1.10%-90K
Other equity interest
32.56%2.12M
32.56%2.12M
-37.04%1.77M
-33.90%1.45M
-13.80%1.9M
60.99%1.6M
60.99%1.6M
44.37%2.81M
32.13%2.19M
64.65%2.2M
Total stockholders'equity
56.62%2.76M
56.62%2.76M
-50.24%1.46M
-40.50%1.53M
-63.76%1.32M
831.75%1.76M
831.75%1.76M
306.10%2.93M
273.19%2.58M
160.47%3.63M
Total equity
56.62%2.76M
56.62%2.76M
-50.24%1.46M
-40.50%1.53M
-63.76%1.32M
831.75%1.76M
831.75%1.76M
306.10%2.93M
273.19%2.58M
160.47%3.63M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 205.43%2.14M205.43%2.14M-61.04%983K-48.51%1.23M-81.94%588K29.39%700K29.39%700K120.73%2.52M171.02%2.39M104.97%3.26M
-Cash and cash equivalents 205.43%2.14M205.43%2.14M-61.04%983K-48.51%1.23M-81.94%588K29.39%700K29.39%700K120.73%2.52M171.02%2.39M104.97%3.26M
Receivables -29.92%89K-29.92%89K-52.90%122K-76.54%84K-65.38%135K29.59%127K29.59%127K215.85%259K165.19%358K50.58%390K
-Taxes receivable -37.10%78K-37.10%78K------------39.33%124K39.33%124K------------
-Other receivables 266.67%11K266.67%11K-52.90%122K-76.54%84K-65.38%135K-66.67%3K-66.67%3K215.85%259K165.19%358K50.58%390K
Prepaid assets -87.60%95K-87.60%95K--0--600K--600K571.93%766K571.93%766K------------
Restricted cash 580.49%279K580.49%279K0.00%41K0.00%41K28.13%41K-96.66%41K-96.66%41K-24.07%41K-24.07%41K-40.74%32K
Total current assets 59.18%2.6M59.18%2.6M-59.40%1.15M-29.85%1.95M-62.90%1.36M-17.56%1.63M-17.56%1.63M120.72%2.82M160.43%2.78M93.42%3.68M
Non current assets
Net PPE 7.06%864K7.06%864K11.50%882K79.33%911K66.88%776K329.26%807K329.26%807K499.24%791K257.75%508K225.17%465K
-Gross PPE 26.88%1.11M26.88%1.11M11.50%882K79.33%911K66.88%776K336.82%878K336.82%878K499.24%791K257.75%508K225.17%465K
-Accumulated depreciation -252.11%-250K-252.11%-250K-------------446.15%-71K-446.15%-71K------------
Other non current assets --618K--618K--618K----------------------------
Total non current assets 83.64%1.48M83.64%1.48M89.63%1.5M79.33%911K66.88%776K329.26%807K329.26%807K499.24%791K257.75%508K225.17%465K
Total assets 67.27%4.08M67.27%4.08M-26.78%2.65M-13.00%2.86M-48.33%2.14M12.49%2.44M12.49%2.44M156.13%3.61M171.84%3.29M102.64%4.14M
Liabilities
Current liabilities
Current debt and capital lease obligation 1,800.00%38K1,800.00%38K-------------88.89%2K-88.89%2K------------
-Current capital lease obligation 1,800.00%38K1,800.00%38K-------------88.89%2K-88.89%2K------------
Payables -54.39%26K-54.39%26K88.59%496K82.75%678K258.82%366K14.00%57K14.00%57K-25.71%263K142.48%371K-61.94%102K
-Other payable -54.39%26K-54.39%26K88.59%496K82.75%678K258.82%366K14.00%57K14.00%57K447.92%263K142.48%371K-61.94%102K
Current accrued expenses 103.54%690K103.54%690K112.79%366K90.17%329K-19.05%187K-38.14%339K-38.14%339K-36.06%172K-39.08%173K-23.26%231K
Current deferred liabilities ----------------------0--0--0--2K--29K
Other current liabilities --235K--235K--------------------------------
Current liabilities 148.49%989K148.49%989K98.16%862K84.43%1.01M52.76%553K-79.14%398K-79.14%398K-30.18%435K24.94%546K-36.38%362K
Non current liabilities
Long term debt and capital lease obligation 125.81%70K125.81%70K154.84%79K264.00%91K29.17%31K1,450.00%31K1,450.00%31K933.33%31K177.78%25K84.62%24K
-Long term capital lease obligation 125.81%70K125.81%70K154.84%79K264.00%91K29.17%31K1,450.00%31K1,450.00%31K933.33%31K177.78%25K84.62%24K
Long term accounts payable and other payables -29.49%55K-29.49%55K-39.44%43K-43.75%36K-28.21%56K9.86%78K9.86%78K10.94%71K-14.67%64K14.71%78K
Non current deferred liabilities 21.97%211K21.97%211K37.58%205K141.46%198K291.49%184K--173K--173K--149K--82K--47K
Total non current liabilities 19.15%336K19.15%336K30.28%327K90.06%325K81.88%271K286.30%282K286.30%282K274.63%251K103.57%171K83.95%149K
Total liabilities 94.85%1.33M94.85%1.33M73.32%1.19M85.77%1.33M61.25%824K-65.67%680K-65.67%680K-0.58%686K37.62%717K-21.38%511K
Shareholders'equity
Share capital --0--0--0--0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
Additional paid-in capital 34.04%26.09M34.04%26.09M33.97%23.82M35.21%22.75M23.74%20.41M46.37%19.47M46.37%19.47M46.29%17.78M49.21%16.83M46.38%16.5M
Retained earnings -33.42%-25.48M-33.42%-25.48M-37.23%-24.09M-38.76%-22.62M-38.71%-20.78M-35.88%-19.1M-35.88%-19.1M-31.79%-17.55M-34.05%-16.3M-34.67%-14.98M
Gains losses not affecting retained earnings 116.34%33K116.34%33K58.72%-45K67.38%-46K-142.22%-218K-348.89%-202K-348.89%-202K-81.67%-109K-67.86%-141K1.10%-90K
Other equity interest 32.56%2.12M32.56%2.12M-37.04%1.77M-33.90%1.45M-13.80%1.9M60.99%1.6M60.99%1.6M44.37%2.81M32.13%2.19M64.65%2.2M
Total stockholders'equity 56.62%2.76M56.62%2.76M-50.24%1.46M-40.50%1.53M-63.76%1.32M831.75%1.76M831.75%1.76M306.10%2.93M273.19%2.58M160.47%3.63M
Total equity 56.62%2.76M56.62%2.76M-50.24%1.46M-40.50%1.53M-63.76%1.32M831.75%1.76M831.75%1.76M306.10%2.93M273.19%2.58M160.47%3.63M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More